{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T22:55:48Z","timestamp":1773096948748,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004156","name":"Mahidol University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004156","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-12795-9","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T06:18:50Z","timestamp":1770272330000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Rifampicin-resistant tuberculosis in Nangarhar, Afghanistan: prevalence and risk factors"],"prefix":"10.1186","volume":"26","author":[{"given":"Shah Agha","family":"Salehi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sant","family":"Muangnoicharoen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natthida","family":"Sriboonvorakul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janjira","family":"Thaipadungpanit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jittima","family":"Dhitavat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Udomsak","family":"Silachamroon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wiwat","family":"Chancharoenthana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,5]]},"reference":[{"key":"12795_CR1","volume-title":"Global tuberculosis report 2023","author":"World Health Organization","year":"2023","unstructured":"World Health Organization. Global tuberculosis report 2023. Geneva: WHO; 2023."},{"key":"12795_CR2","doi-asserted-by":"publisher","first-page":"107325","DOI":"10.1016\/j.ijid.2024.107325","volume":"150","author":"D Goletti","year":"2025","unstructured":"Goletti D, Meintjes G, Andrade BB, Zumla A, Shan Lee S. Insights from the 2024 WHO global tuberculosis report - more comprehensive action, innovation, and investments required for achieving WHO end TB goals. Int J Infect Dis. 2025;150:107325. https:\/\/doi.org\/10.1016\/j.ijid.2024.107325.","journal-title":"Int J Infect Dis"},{"issue":"8","key":"12795_CR3","doi-asserted-by":"publisher","first-page":"e0237787","DOI":"10.1371\/journal.pone.0237787","volume":"15","author":"A Mesic","year":"2020","unstructured":"Mesic A, Khan WH, Lenglet A, Lynen L, Ishaq S, Phyu EHH, Mar HT, Oraegbu A, Seddiq MK, Amirzada HK, Fernhout J, Kamau C, Ariti C, Gomez D, Decroo T. Translating drug resistant tuberculosis treatment guidelines to reality in war-torn Kandahar, Afghanistan: a retrospective cohort study. PLoS ONE. 2020;15(8):e0237787. https:\/\/doi.org\/10.1371\/journal.pone.0237787.","journal-title":"PLoS ONE"},{"issue":"6","key":"12795_CR4","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.jinf.2018.10.004","volume":"77","author":"IS Pradipta","year":"2018","unstructured":"Pradipta IS, Forsman LD, Bruchfeld J, Hak E, Alffenaar JW. Risk factors of multidrug-resistant tuberculosis: A global systematic review and meta-analysis. J Infect. 2018;77(6):469\u201378. https:\/\/doi.org\/10.1016\/j.jinf.2018.10.004.","journal-title":"J Infect"},{"issue":"6","key":"12795_CR5","doi-asserted-by":"publisher","first-page":"e0270003","DOI":"10.1371\/journal.pone.0270003","volume":"17","author":"Y Xi","year":"2022","unstructured":"Xi Y, Zhang W, Qiao RJ, Tang J. Risk factors for multidrug-resistant tuberculosis: A worldwide systematic review and meta-analysis. PLoS ONE. 2022;17(6):e0270003. https:\/\/doi.org\/10.1371\/journal.pone.0270003.","journal-title":"PLoS ONE"},{"issue":"2","key":"12795_CR6","doi-asserted-by":"publisher","first-page":"e0171800","DOI":"10.1371\/journal.pone.0171800","volume":"12","author":"KA Alene","year":"2017","unstructured":"Alene KA, Viney K, McBryde ES, Clements AC. Spatial patterns of multidrug resistant tuberculosis and relationships to socio-economic, demographic and household factors in Northwest Ethiopia. PLoS ONE. 2017;12(2):e0171800. https:\/\/doi.org\/10.1371\/journal.pone.0171800.","journal-title":"PLoS ONE"},{"issue":"8","key":"12795_CR7","doi-asserted-by":"publisher","first-page":"646","DOI":"10.5588\/ijtld.23.0123","volume":"27","author":"S Ahmed","year":"2023","unstructured":"Ahmed S, Lotia-Farrukh I, Khan PY, Adnan S, Sodho JS, Bano S, Siddiqui MR, Ghafoor A, Isani AK, Salahuddin N, Khan U. High prevalence of multidrug-resistant TB among household contacts in a high burden setting. Int J Tuberc Lung Dis. 2023;27(8):646\u20138. https:\/\/doi.org\/10.5588\/ijtld.23.0123.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"10","key":"12795_CR8","doi-asserted-by":"publisher","first-page":"e296","DOI":"10.1371\/journal.pmed.0040296","volume":"4","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP, STROBE Initiative. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med. 2007;4(10):e296. https:\/\/doi.org\/10.1371\/journal.pmed.0040296.","journal-title":"PLoS Med"},{"key":"12795_CR9","volume-title":"Definitions and reporting framework for tuberculosis\u20142013 revision (updated December 2014)","author":"World Health Organization","year":"2014","unstructured":"World Health Organization. Definitions and reporting framework for tuberculosis\u20142013 revision (updated December 2014). Geneva: WHO; 2014."},{"key":"12795_CR10","volume-title":"Consolidated guidelines on tuberculosis. Module 3: Diagnosis\u2014Rapid diagnostics for tuberculosis detection. 2021 update","author":"World Health Organization","year":"2021","unstructured":"World Health Organization. Consolidated guidelines on tuberculosis. Module 3: Diagnosis\u2014Rapid diagnostics for tuberculosis detection. 2021 update. Geneva: WHO; 2021."},{"key":"12795_CR11","volume-title":"Mycobacteriology laboratory manual","author":"Global Laboratory Initiative (GLI)","year":"2014","unstructured":"Global Laboratory Initiative (GLI). Mycobacteriology laboratory manual. 1st ed. Geneva: Stop TB Partnership; 2014.","edition":"1"},{"key":"12795_CR12","volume-title":"Technical manual for drug susceptibility testing of medicines used in the treatment of tuberculosis","author":"World Health Organization","year":"2018","unstructured":"World Health Organization. Technical manual for drug susceptibility testing of medicines used in the treatment of tuberculosis. 2nd ed. Geneva: WHO; 2018.","edition":"2"},{"key":"12795_CR13","volume-title":"Epi Info\u2122, version 7.2.4.0","author":"Centers for Disease Control and Prevention","year":"2020","unstructured":"Centers for Disease Control and Prevention. Epi Info\u2122, version 7.2.4.0. Atlanta, GA: CDC; 2020."},{"key":"12795_CR14","unstructured":"World Health Organization. WHO treatment guidelines for drug-resistant tuberculosis, 2016 update (with subsequent updates to pre-XDR\/XDR definitions). Geneva: WHO; 2016."},{"key":"12795_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/9781118548387","volume-title":"Applied logistic regression","author":"DW Hosmer","year":"2013","unstructured":"Hosmer DW, Lemeshow S, Sturdivant RX. Applied logistic regression. 3rd ed. Hoboken, NJ: Wiley; 2013.","edition":"3"},{"key":"12795_CR16","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s11135-006-9018-6","volume":"41","author":"RM O\u2019Brien","year":"2007","unstructured":"O\u2019Brien RM. A caution regarding rules of thumb for variance inflation factors. Qual Quant. 2007;41:673\u201390.","journal-title":"Qual Quant"},{"key":"12795_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4899-4541-9","volume-title":"An introduction to the bootstrap","author":"B Efron","year":"1993","unstructured":"Efron B, Tibshirani RJ. An introduction to the bootstrap. New York: Chapman & Hall\/CRC; 1993."},{"key":"12795_CR18","volume-title":"IBM SPSS statistics for Windows, version 27.0","author":"IBM Corp","year":"2020","unstructured":"IBM Corp. IBM SPSS statistics for Windows, version 27.0. Armonk, NY: IBM Corp; 2020."},{"issue":"20","key":"12795_CR19","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World Medical Association","year":"2013","unstructured":"World Medical Association. World medical association declaration of helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191\u20134. https:\/\/doi.org\/10.1001\/jama.2013.281053.","journal-title":"JAMA"},{"issue":"1","key":"12795_CR20","doi-asserted-by":"publisher","first-page":"e0147529","DOI":"10.1371\/journal.pone.0147529","volume":"11","author":"I Ullah","year":"2016","unstructured":"Ullah I, Javaid A, Tahir Z, Ullah O, Shah AA, Hasan F, Ayub N. Pattern of drug resistance and risk factors associated with development of drug resistant Mycobacterium tuberculosis in Pakistan. PLoS ONE. 2016;11(1):e0147529. https:\/\/doi.org\/10.1371\/journal.pone.0147529.","journal-title":"PLoS ONE"},{"issue":"3","key":"12795_CR21","doi-asserted-by":"publisher","first-page":"285","DOI":"10.18502\/ijm.v14i3.9754","volume":"14","author":"K Ansarin","year":"2022","unstructured":"Ansarin K, Sahebi L. Pattern of drug resistant Mycobacterium tuberculosis in the West and Northwest of Iran: a meta-analysis. Iran J Microbiol. 2022;14(3):285\u201390. https:\/\/doi.org\/10.18502\/ijm.v14i3.9754.","journal-title":"Iran J Microbiol"},{"issue":"1","key":"12795_CR22","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s40249-023-01107-x","volume":"12","author":"N Salari","year":"2023","unstructured":"Salari N, Kanjoori AH, Hosseinian-Far A, Hasheminezhad R, Mansouri K, Mohammadi M. Global prevalence of drug-resistant tuberculosis: a systematic review and meta-analysis. Infect Dis Poverty. 2023;12(1):57. https:\/\/doi.org\/10.1186\/s40249-023-01107-x.","journal-title":"Infect Dis Poverty"},{"issue":"1","key":"12795_CR23","doi-asserted-by":"publisher","first-page":"17552","DOI":"10.1038\/s41598-020-74432-y","volume":"10","author":"SS Shivekar","year":"2020","unstructured":"Shivekar SS, Kaliaperumal V, Brammacharry U, Sakkaravarthy A, Raj CKV, Alagappan C, Muthaiah M. Prevalence and factors associated with multidrug-resistant tuberculosis in South India. Sci Rep. 2020;10(1):17552. https:\/\/doi.org\/10.1038\/s41598-020-74432-y.","journal-title":"Sci Rep"},{"issue":"1","key":"12795_CR24","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/tmi.13502","volume":"26","author":"P Kamolwat","year":"2021","unstructured":"Kamolwat P, Nateniyom S, Chaiprasert A, Disratthakit A, Mahasirimongkol S, Yamada N, Smithtikarn S. Prevalence and associated risk factors of drug-resistant tuberculosis in Thailand: results from the fifth national anti-tuberculosis drug resistance survey. Trop Med Int Health. 2021;26(1):45\u201353. https:\/\/doi.org\/10.1111\/tmi.13502.","journal-title":"Trop Med Int Health"},{"issue":"1","key":"12795_CR25","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1186\/s12879-022-07598-7","volume":"22","author":"I Bykov","year":"2022","unstructured":"Bykov I, Dyachenko O, Ratmanov P, Liu H, Liang L, Wu Q. Factors contributing to the high prevalence of multidrug-resistance\/Rifampin-resistance in patients with tuberculosis: an epidemiological cross sectional and qualitative study from Khabarovsk Krai region of Russia. BMC Infect Dis. 2022;22(1):612. https:\/\/doi.org\/10.1186\/s12879-022-07598-7.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"12795_CR26","first-page":"208","volume":"24","author":"MA ul Manan","year":"2018","unstructured":"ul Manan MA, Naqvi S, Mushtaq A, Shafqat M. Prevalence of pre-XDR-TB and XDR-TB among MDR-TB patients. Pak J Chest Med. 2018;24(4):208\u201311.","journal-title":"Pak J Chest Med"},{"key":"12795_CR27","unstructured":"Adwani S, Desai UD, Joshi JM. Prevalence of pre-extensively drug-resistant tuberculosis (Pre XDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) among pulmonary multidrug resistant tuberculosis (MDR-TB) at a tertiary care center in Mumbai. J Krishna Inst Med Sci Univ. 2016;5(3)."},{"key":"12795_CR28","doi-asserted-by":"publisher","first-page":"100430","DOI":"10.1016\/j.jctube.2024.100430","volume":"35","author":"S Abbasian","year":"2024","unstructured":"Abbasian S, Heidari H, Abbasi Tadi D, Kardan-Yamchi J, Taji A, Darbandi A, Asadollahi P, Maleki A, Kazemian H. Epidemiology of first- and second-line drugs-resistant pulmonary tuberculosis in Iran: systematic review and meta-analysis. J Clin Tuberc Other Mycobact Dis. 2024;35:100430. https:\/\/doi.org\/10.1016\/j.jctube.2024.100430.","journal-title":"J Clin Tuberc Other Mycobact Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-12795-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12795-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12795-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T12:36:35Z","timestamp":1773059795000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-12795-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12795"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-12795-9","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,5]]},"assertion":[{"value":"20 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by Mahidol University (MUTM 2023-068-01\/02) and the Research Ethics Committee of Nangarhar Medical Faculty (NMF-REC-014-2023; Written informed consent was obtained from all participants or their caregivers, as applicable. for participants unable to provide a written signature due to illiteracy, informed consent was documented using a thumbprint in the presence of an independent witness after ensuring that the study procedures were clearly explained and voluntarily agreed upon. The study was conducted in accordance with the ethical principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"518"}}